Abstract
Background and aims: To analyze effectiveness and safety of BiPAP Vision device for NIV in children under 30 kilograms with acute respiratory failure.
Methods: Retrospective cohort study with consecutive sampling of patients treated with BiPAP Vision for ARF admitted to PICU between 2008- 2009. Patients younger than 3 months, patients with previous intubation during admission or those with palliative indication for NIV were excluded. Patient's demographic data, underlying disease, physiologic data (including Hemoglobin saturation / FiO2 ratio (SF)) previous, at start point of NIV, and at 2, 8 and 12 hours were collected. NIV failure, defined as need for intubation, was the primary outcome. Descriptive, Uni- and Multivariate statistic analysis was performed.
Results: The sample consists of 194 patients. 112 were male (57,7%). Median age was 2.27 (range 0.25 - 18) years. 103 patients weighted less than 30 kg. NIV failure occurs in 56 patients (23.93%; 95%CI = 13.25- 32.53%). Duration of NIV treatment ranged 0 - 320 (median 38.5) hours. Median PICU length of stay (LOS) was 7,2 (range 1- 45) days. No statistical difference was observed in NIV's failure in patients weighting under 30 kg (< 30Kg 20%, >30 kg 32.6%) p=0.112. No complications were observed.
Conclusion: BiPAP Vision is a safe and an effective device to provide NIV in ARF in children under 30 kg.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pons, M., Esteban, E., Ortiz, J. et al. 1357 Bipap Vision for Niv in Children Under 30 Kg. Report of Effectiveness and Safety. Pediatr Res 68 (Suppl 1), 672 (2010). https://doi.org/10.1203/00006450-201011001-01357
Issue Date:
DOI: https://doi.org/10.1203/00006450-201011001-01357